Autologous platelet-rich plasma (PRP) infusions and biomarkers of ovarian and endometrial rejuvenation and aging mitigation
World Congress on Embryology and In vitro Fertilization
November 02-03, 2017 | Chicago, USA
Aaron Traywick and E Scott Sills
Inovium Rejuvenation, USA Center for Advanced Genetics, USA
Posters & Accepted Abstracts : Res Rep Gynaecol Obstet
The purpose of two separate clinical trials was to study and evaluate the beneficial effects of infusions of autologous platelet-rich plasma on fertility, the aging process, and general and reproductive health using blood and hormone biomarkers in peri-menopausal and menopausal women seeking fertility. Data generated as a result of the trial will be used to support additional organ-specific and disease specific PRP-based treatments, particularly in brain and musculoskeletal tissue and stem cell rejuvenation treatments in women, as part of an ongoing research collaborative with researchers at UC-Berkeley. The most prominent data as generated from nearly 100 women participating in the 2017 trials will be presented.